These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 27244269)
1. Cloning and Expression of L1 Protein Human Papillomavirus Type 31 Isolated from Iranian Patients in Escherichia coli. Hajmohammadi S; Rassi H Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):181-5. PubMed ID: 27244269 [TBL] [Abstract][Full Text] [Related]
2. Developments in L2-based human papillomavirus (HPV) vaccines. Schellenbacher C; Roden RBS; Kirnbauer R Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616 [TBL] [Abstract][Full Text] [Related]
3. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer. Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172 [TBL] [Abstract][Full Text] [Related]
5. Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody. Liu DW; Chang JL; Tsao YP; Huang CW; Kuo SW; Chen SL Int J Cancer; 2005 Jan; 113(1):93-100. PubMed ID: 15386434 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic. Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614 [TBL] [Abstract][Full Text] [Related]
7. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity. Schädlich L; Senger T; Kirschning CJ; Müller M; Gissmann L Vaccine; 2009 Mar; 27(10):1511-22. PubMed ID: 19174177 [TBL] [Abstract][Full Text] [Related]
8. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110 [TBL] [Abstract][Full Text] [Related]
9. N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro. Wei M; Wang D; Li Z; Song S; Kong X; Mo X; Yang Y; He M; Li Z; Huang B; Lin Z; Pan H; Zheng Q; Yu H; Gu Y; Zhang J; Li S; Xia N Emerg Microbes Infect; 2018 Sep; 7(1):160. PubMed ID: 30254257 [TBL] [Abstract][Full Text] [Related]
10. Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. Pinto LA; Viscidi R; Harro CD; Kemp TJ; García-Piñeres AJ; Trivett M; Demuth F; Lowy DR; Schiller JT; Berzofsky JA; Hildesheim A Virology; 2006 Sep; 353(2):451-62. PubMed ID: 16863657 [TBL] [Abstract][Full Text] [Related]
11. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit. Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581 [TBL] [Abstract][Full Text] [Related]
12. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography. Baek JO; Seo JW; Kim IH; Kim CH Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445 [TBL] [Abstract][Full Text] [Related]
13. Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors. Nieto K; Kern A; Leuchs B; Gissmann L; Müller M; Kleinschmidt JA Antivir Ther; 2009; 14(8):1125-37. PubMed ID: 20032542 [TBL] [Abstract][Full Text] [Related]
14. Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli. Wang D; Fan F; Li Z; Liu X; Song S; Wei S; He M; Lin Y; Li Z; Wei M; Yu H; Gu Y; Li S; Xia N Protein Expr Purif; 2017 May; 133():110-120. PubMed ID: 28267627 [TBL] [Abstract][Full Text] [Related]
15. VLP production in Leishmania tarentolae: A novel expression system for purification and assembly of HPV16 L1. Bolhassani A; Shirbaghaee Z; Agi E; Davoudi N Protein Expr Purif; 2015 Dec; 116():7-11. PubMed ID: 26304732 [TBL] [Abstract][Full Text] [Related]
16. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins]. Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206 [TBL] [Abstract][Full Text] [Related]
17. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine. Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccines. Stanley MA Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836 [TBL] [Abstract][Full Text] [Related]
19. Strategies for the prevention of cervical cancer by human papillomavirus vaccination. Williamson AL; Passmore JA; Rybicki EP Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392 [TBL] [Abstract][Full Text] [Related]
20. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity]. Hao DF; Ma ZH; Wang YP; Rexidan ; Zhang FC Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):428-31. PubMed ID: 15989783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]